CAR-T cell immunotherapy treatment has transformed the treatment of some cancers in some patients. But which patient factors determine the success of CAR-T therapies, and how universal is the applicability of CAR-T and its variations such as CAR-NK?
In this webinar, an expert panel will discuss how feasible it is to predict the potential of therapies based on patients’ immunological states, and explore what can be done to adjust CAR-T or other immunotherapies to accommodate those patients.
Attend this webinar for insight into: